Last reviewed · How we verify

NCT06576817

High-intensity Interval Circuit Training in People With Parkinson Disease

Completed NA Last updated 27 March 2026
What this trial tests

NA trial testing High intensity circuit exercise class - Lower and upper extremity in Parkinson Disease in 64 participants. Completed in 30 November 2025.

Timeline
15 February 2024
Primary endpoint
30 November 2025
30 November 2025

Quick facts

Lead sponsorPacific Northwest University of Health Sciences
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment64
Start date15 February 2024
Primary completion30 November 2025
Estimated completion30 November 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Pacific Northwest University of Health Sciences

Who can join

Eligibility, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of the study is to compare different types of high intensity circuit exercises over an 8-class training series in people with Parkinson disease. The main question it aims to answer is: -Does including arm and hand exercises with leg exercises improve reaction time, balance, functional measures, gait speed and quality of life? This group will be compared to a group that only does leg exercises. Participants will be asked to participate in 8 high intensity circuit exercise classes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

Other Pacific Northwest University of Health Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06576817.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing